UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 506

Sortiert nach

A Proliferation Inducing Ligand (APRIL) targeted antibody is a safe and effective treatment of murine IgA nephropathy

Kidney international, 2019-07, Vol.96 (1), p.104-116

2019

Link zum Volltext

Verfügbarkeit prüfen

Identification and Characterization of Broadly Neutralizing Human Monoclonal Antibodies Directed against the E2 Envelope Glycoprotein of Hepatitis C Virus

Journal of Virology, 2009-12, Vol.83 (23), p.12473-12482

2009

Link zum Volltext

Verfügbarkeit prüfen

A broadly neutralizing human monoclonal antibody is effective against H7N9

Proceedings of the National Academy of Sciences - PNAS, 2015-09, Vol.112 (35), p.10890-10895

2015

Link zum Volltext

Verfügbarkeit prüfen

Clinical and virological responses to a broad-spectrum human monoclonal antibody in an influenza virus challenge study

Antiviral research, 2020-12, Vol.184, p.104763-104763, Article 104763

2020

Link zum Volltext

Verfügbarkeit prüfen

The Hemagglutinin Stem-Binding Monoclonal Antibody VIS410 Controls Influenza Virus-Induced Acute Respiratory Distress Syndrome

Antimicrobial agents and chemotherapy, 2016-04, Vol.60 (4), p.2118-2131

2016

Link zum Volltext

Verfügbarkeit prüfen

Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous Sibeprenlimab in Healthy Participants

Clinical pharmacology in drug development, 2023-12, Vol.12 (12), p.1211-1220

2023

Link zum Volltext

Verfügbarkeit prüfen

Safety and Upper Respiratory Pharmacokinetics of the Hemagglutinin Stalk-Binding Antibody VIS410 Support Treatment and Prophylaxis Based on Population Modeling of Seasonal Influenza A Outbreaks

EBioMedicine, 2016-03, Vol.5 (C), p.147-155

2016

Link zum Volltext

Verfügbarkeit prüfen

Identification of a Human Monoclonal Antibody To Replace Equine Diphtheria Antitoxin for Treatment of Diphtheria Intoxication

Infection and Immunity, 2013-11, Vol.81 (11), p.3992-4000

2013

Link zum Volltext

Verfügbarkeit prüfen

G glycoprotein amino acid residues required for human monoclonal antibody RAB1 neutralization are conserved in rabies virus street isolates

Antiviral research, 2011-08, Vol.91 (2), p.187-194

2011

Link zum Volltext

Verfügbarkeit prüfen

Identification and characterization of a human monoclonal antibody that potently neutralizes a broad panel of rabies virus isolates

Vaccine, 2007-04, Vol.25 (15), p.2800-2810

2007

Link zum Volltext

Verfügbarkeit prüfen

MO258SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF VIS649, AN APRIL-NEUTRALIZING IGG2 MONOCLONAL ANTIBODY, IN HEALTHY VOLUNTEERS: PHASE 1, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE ASCENDING DOSE STUDY

Nephrology, dialysis, transplantation, 2021-05, Vol.36 (Supplement_1)

2021

Link zum Volltext

Verfügbarkeit prüfen

MO283IMPACT OF VIS649, AN APRIL-NEUTRALIZING IGG2 MONOCLONAL ANTIBODY, ON TETANUS- AND DIPHTHERIA-TOXOID VACCINATION-ELICITED IMMUNE RESPONSES IN HEALTHY VOLUNTEERS: PHASE 1, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY

Nephrology, dialysis, transplantation, 2021-05, Vol.36 (Supplement_1)

2021

Link zum Volltext

Verfügbarkeit prüfen

Treatment with Monoclonal Antibodies against Clostridium difficile Toxins

The New England journal of medicine, 2010-01, Vol.362 (3), p.197-205

2010

Link zum Volltext

Verfügbarkeit prüfen

Safety and efficacy of monoclonal antibody VIS410 in adults with uncomplicated influenza A infection: Results from a randomized, double-blind, phase-2, placebo-controlled study

EBioMedicine, 2019-02, Vol.40, p.574-582

2019

Link zum Volltext

Verfügbarkeit prüfen

Experiences of a clinical leadership programme and its subsequent impact : a constructivist inquiry

Sloan, Susan

2019

Link zum Volltext
ProQuest

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VIS649 (Sibeprenlimab), an APRIL-Neutralizing IgG 2 Monoclonal Antibody, in Healthy Volunteers

Kidney international reports, 2022-05, Vol.7 (5), p.993

2022

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Alternate Patient Education Methods Regarding Treatment-Related Side Effects in Preparation for Radiation Therapy

Journal of medical imaging and radiation sciences, 2020-09, Vol.51 (3), p.S16-S16

2020

Link zum Volltext

Verfügbarkeit prüfen

Anti-Influenza Antibody VIS410 Targets a Broadly Conserved Epitope on Hemagglutinin

Open forum infectious diseases, 2016-12, Vol.3 (suppl_1)

2016

Link zum Volltext

Verfügbarkeit prüfen

Recombinant Insulin-Like Growth Factor (IGF)-I Treatment in Short Children with Low IGF-I Levels: First-Year Results from a Randomized Clinical Trial

The journal of clinical endocrinology and metabolism, 2010-02, Vol.95 (2), p.611-619

2010

Link zum Volltext

Verfügbarkeit prüfen

Abstract B103: Time for a change in breast cancer screening? A survey of female physicians’ perception of 2009 USPSTF guidelines on breast cancer screening

Cancer epidemiology, biomarkers & prevention, 2010-10, Vol.19 (10_Supplement), p.B103-B103

2010

Link zum Volltext

Verfügbarkeit prüfen

Safety and efficacy of monoclonal antibody VIS410 in adults with uncomplicated influenza A infection: Results from a randomized, double-blind, phase-2, placebo-controlled studyResearch in context

EBioMedicine, 2019-02, Vol.40, p.574-582

2019

Link zum Volltext

Verfügbarkeit prüfen

Delayed Treatment of Panuveitis in a Combat Zone

Optometry (Saint Louis, Mo.), 2011-06, Vol.82 (6), p.369-369

2011

Link zum Volltext

Verfügbarkeit prüfen

IRVAN Syndrome in an Asymptomatic Soldier

Optometry (Saint Louis, Mo.), 2011-06, Vol.82 (6), p.361-362

2011

Link zum Volltext

Verfügbarkeit prüfen

Optic Neuritis as the Initial Presentation in an Atypical Multiple Sclerosis Patient

Optometry (Saint Louis, Mo.), 2011-06, Vol.82 (6), p.369-370

2011

Link zum Volltext

Verfügbarkeit prüfen

751b Phase II Efficacy of Human Monoclonal Antibody Treatment to Prevent C. difficile Recurrence

Gastroenterology (New York, N.Y. 1943), 2009, Vol.136 (5), p.A-115-A-115

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 506

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(334)
Mit Volltextzugriff
(436)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(505)
Japanisch
(43)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

A Proliferation Inducing Ligand (APRIL) targeted antibody is a safe and effective treatment of murine IgA nephropathy

Identification and Characterization of Broadly Neutralizing Human Monoclonal Antibodies Directed against the E2 Envelope Glycoprotein of Hepatitis C Virus

A broadly neutralizing human monoclonal antibody is effective against H7N9

Clinical and virological responses to a broad-spectrum human monoclonal antibody in an influenza virus challenge study

The Hemagglutinin Stem-Binding Monoclonal Antibody VIS410 Controls Influenza Virus-Induced Acute Respiratory Distress Syndrome

Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous Sibeprenlimab in Healthy Participants

Safety and Upper Respiratory Pharmacokinetics of the Hemagglutinin Stalk-Binding Antibody VIS410 Support Treatment and Prophylaxis Based on Population Modeling of Seasonal Influenza A Outbreaks

Identification of a Human Monoclonal Antibody To Replace Equine Diphtheria Antitoxin for Treatment of Diphtheria Intoxication

G glycoprotein amino acid residues required for human monoclonal antibody RAB1 neutralization are conserved in rabies virus street isolates

Identification and characterization of a human monoclonal antibody that potently neutralizes a broad panel of rabies virus isolates

MO258SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF VIS649, AN APRIL-NEUTRALIZING IGG2 MONOCLONAL ANTIBODY, IN HEALTHY VOLUNTEERS: PHASE 1, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE ASCENDING DOSE STUDY

MO283IMPACT OF VIS649, AN APRIL-NEUTRALIZING IGG2 MONOCLONAL ANTIBODY, ON TETANUS- AND DIPHTHERIA-TOXOID VACCINATION-ELICITED IMMUNE RESPONSES IN HEALTHY VOLUNTEERS: PHASE 1, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY

Treatment with Monoclonal Antibodies against Clostridium difficile Toxins

Safety and efficacy of monoclonal antibody VIS410 in adults with uncomplicated influenza A infection: Results from a randomized, double-blind, phase-2, placebo-controlled study

Experiences of a clinical leadership programme and its subsequent impact : a constructivist inquiry

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VIS649 (Sibeprenlimab), an APRIL-Neutralizing IgG 2 Monoclonal Antibody, in Healthy Volunteers

Evaluation of Alternate Patient Education Methods Regarding Treatment-Related Side Effects in Preparation for Radiation Therapy

Anti-Influenza Antibody VIS410 Targets a Broadly Conserved Epitope on Hemagglutinin

Recombinant Insulin-Like Growth Factor (IGF)-I Treatment in Short Children with Low IGF-I Levels: First-Year Results from a Randomized Clinical Trial

Abstract B103: Time for a change in breast cancer screening? A survey of female physicians’ perception of 2009 USPSTF guidelines on breast cancer screening

Safety and efficacy of monoclonal antibody VIS410 in adults with uncomplicated influenza A infection: Results from a randomized, double-blind, phase-2, placebo-controlled studyResearch in context

Delayed Treatment of Panuveitis in a Combat Zone

IRVAN Syndrome in an Asymptomatic Soldier

Optic Neuritis as the Initial Presentation in an Atypical Multiple Sclerosis Patient

751b Phase II Efficacy of Human Monoclonal Antibody Treatment to Prevent C. difficile Recurrence

Suchergebnisse filtern